Related Experiment Video
Updated: Aug 10, 2026
12:03
Myocardial Infarction and Functional Outcome Assessment in Pigs
Published on: April 25, 2014
T lymphocyte beta 2-adrenergic receptor function and density after acute myocardial infarction
R A McCoy1, G D Clifton, D C Booth
1College of Pharmacy, University of Kentucky, Lexington, USA.
Pharmacotherapy
|March 1, 1997
Summary
T lymphocyte beta 2-adrenergic receptor (beta 2AR) density and function showed no significant differences between acute myocardial infarction and stable coronary artery disease patients. Further research is needed to confirm potential increases in beta 2AR after acute myocardial infarction.
Area of Science:
- Immunology
- Cardiology
- Pharmacology
Background:
- The beta 2-adrenergic receptor (beta 2AR) plays a role in immune cell function.
- Understanding beta 2AR changes in cardiovascular disease is crucial for therapeutic strategies.
Purpose of the Study:
- To compare T lymphocyte beta 2AR density and function in patients with acute myocardial infarction (AMI) versus stable coronary artery disease (CAD).
Main Methods:
- Quantified T lymphocyte beta 2AR density using radioligand binding (125IPIN).
- Assessed T lymphocyte function via in vitro cyclic adenosine 3',5'-monophosphate (cAMP) production.
- Compared these parameters between 15 AMI patients and 10 stable CAD patients.
Main Results:
- T lymphocyte beta 2AR density was not significantly different between AMI (823.8 +/- 480 sites/cell) and stable CAD (629 +/- 301 sites/cell) groups.
- No significant differences in T lymphocyte cAMP production were observed at baseline or after isoproterenol stimulation between the groups.
Conclusions:
- Current findings suggest no significant alteration in T lymphocyte beta 2AR density or function in the early stages of acute myocardial infarction compared to stable coronary artery disease.
- Further investigation is warranted to ascertain if beta 2AR levels on T lymphocytes are elevated following acute myocardial infarction.
Related Concept Videos
01:26Adrenergic Receptors: β Subtype
β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
01:31Adrenergic Antagonists: ɑ and β-Receptor Blockers
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is clinically...
01:17Antihypertensive Drugs: Action of β1 Blockers
β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this, β1-blockers...
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
01:21Myocarditis I: Introduction
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
01:27Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...